Microfluidic Extracellular Vesicle Screening Through Cell-Specific Uptake
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing extracellular vesicles, particularly exosomes, are limited by the need for volume requirements, time, sample complexity, heterogeneity, and the inability to differentiate exosomes of different origins in a sample, which hinders effective cancer diagnosis and metastasis analysis.
Innovation Solution
A microfluidic device and method that facilitates the incubation of extracellular vesicles with organ-specific cell types, measuring their uptake, and determining cellular origin by comparing uptake levels and secretion patterns, using detectable markers and biomarkers like tetraspanin proteins and annexin V.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current separation methods are used for cancer-specific exosomes, then exosomes can be isolated, but the methods are limited by volume requirements, time, sample complexity, heterogeneity, and inability to differentiate exosomes of different origins
Solution Approach 1:
The patent segments the complex sample analysis by using multiple cell types (e.g., lung cells, breast cells, prostate cells) in separate wells or chambers. Each cell type specifically uptake exosomes from its corresponding tissue of origin, thereby segmenting the differentiation task across multiple specialized biological components rather than using a single complex separation device
Solution Approach 2:
The patent introduces living cells as intermediary agents between the exosome sample and the detection system. These cells act as biological mediators that selectively uptake exosomes based on tissue-specific receptors, converting the complex problem of exosome differentiation into a simpler cellular uptake measurement
2Productivity
If traditional exosome analysis methods are used, then exosomes can be detected, but volume requirements and time consumption increase
Solution Approach 1:
The patent employs living cells that autonomously perform the exosome uptake and differentiation function without requiring external separation equipment or complex processing steps. The cells self-select and internalize exosomes based on their biological properties, eliminating the need for time-consuming centrifugation, filtration, or chromatography steps that require large sample volumes
Solution Approach 2:
The patent changes the physical state and functional parameters of the detection system by using living cells in an active metabolic state rather than static reagents or equipment. This allows the system to process smaller volumes more efficiently, as the cellular uptake process is highly sensitive and can detect exosomes at low concentrations without requiring large sample inputs
Data Source
AI summary
The present disclosure provides methods, devices, and kits useful for screening or characterizing extracellular vesicles (e.g., exosomes) by monitoring cell-type specific extracellular vesicle uptake and/or cells' feedback responses.